This company has been acquired
CHNG Stock Overview
Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Change Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$27.49 |
| 52 Week High | US$27.59 |
| 52 Week Low | US$18.97 |
| Beta | 1.02 |
| 1 Month Change | 10.94% |
| 3 Month Change | 16.83% |
| 1 Year Change | 30.66% |
| 3 Year Change | 127.38% |
| 5 Year Change | n/a |
| Change since IPO | 83.27% |
Recent News & Updates
UnitedHealth completes acquisition of Change Healthcare
Oct 03Change Healthcare jumps after judge denies DOJ request to block UnitedHealth deal
Sep 19Recent updates
UnitedHealth completes acquisition of Change Healthcare
Oct 03Change Healthcare jumps after judge denies DOJ request to block UnitedHealth deal
Sep 19Change Healthcare gains amid final arguments in DOJ case to block UnitedHealth deal
Sep 08Data misuse risk against UnitedHealth used by DoJ to scuttle Change Healthcare deal - Bloomberg
Aug 11Catalyst watch: Change Health/UNH DOJ court starts, PayPal earnings , unemployment data
Jul 29Change Healthcare: A Healthcare SaaS Opportunity At 11x Free Cash Flow
Feb 14Change Healthcare drops as DOJ sues to block Aon's planned $30B Willis Towers deal
Jun 17Change Healthcare EPS beats by $0.06, beats on revenue
May 26Change Healthcare Inc. 2021 Q3 - Results - Earnings Call Presentation
Feb 04UnitedHealth’s Change deal signals plans to expand Optum – Citi
Jan 06Change Healthcare Inc.: Solving Healthcare's Biggest Challenges
Dec 08Change Healthcare: Good Fundamentals At An Enticing Valuation
Dec 01Change Healthcare Inc. 2021 Q2 - Results - Earnings Call Presentation
Nov 09Shareholder Returns
| CHNG | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0.8% | 2.2% | 1.3% |
| 1Y | 30.7% | 0.9% | 24.4% |
Return vs Industry: CHNG exceeded the US Healthcare Services industry which returned -51.8% over the past year.
Return vs Market: CHNG exceeded the US Market which returned -20% over the past year.
Price Volatility
| CHNG volatility | |
|---|---|
| CHNG Average Weekly Movement | 2.5% |
| Healthcare Services Industry Average Movement | 9.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: CHNG has not had significant price volatility in the past 3 months.
Volatility Over Time: CHNG's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 14,000 | Neil de Crescenzo | www.changehealthcare.com |
Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for revenue cycle management, provider network management, payment accuracy, clinical decision support, value-based payment, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow.
Change Healthcare Inc. Fundamentals Summary
| CHNG fundamental statistics | |
|---|---|
| Market cap | US$9.03b |
| Earnings (TTM) | -US$76.95m |
| Revenue (TTM) | US$3.50b |
2.6x
P/S Ratio-117.3x
P/E RatioIs CHNG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHNG income statement (TTM) | |
|---|---|
| Revenue | US$3.50b |
| Cost of Revenue | US$1.64b |
| Gross Profit | US$1.86b |
| Other Expenses | US$1.93b |
| Earnings | -US$76.95m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 53.06% |
| Net Profit Margin | -2.20% |
| Debt/Equity Ratio | 136.5% |
How did CHNG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/03 08:19 |
| End of Day Share Price | 2022/09/30 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Change Healthcare Inc. is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Zhilin Long | Berenberg |
| Steven Halper | Cantor Fitzgerald & Co. |